Short answer
Steris (STE) filed its Q3 2025 10-Q quarterly report on Nov 6, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $1.5B (up 9.9% year over year) with net income of $192M.
Q3 2025 key financials · XBRL
- Revenue
- $1.5B
- +9.9% YoY · +5.0% QoQ
- Net income
- $192M
- +27.8% YoY · +8.1% QoQ
- Operating margin
- 18.2%
- Gross margin
- 44.2%
- EPS (diluted)
- $1.95
- +28.3% YoY · +8.9% QoQ
Source: XBRL data from the Steris (STE) Q3 2025 10-Q on SEC EDGAR. USD.
Steris Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No newly added risk factors or significant changes to risk profile disclosed compared to most recent 10-K
- Regulatory risk from taxation includes potential impact of changes in tax law necessitating revision of past tax estimates
- Operational risk from divestiture of Dental segment, now discontinued operations, impacting segment reporting and comparability
- Market risk reflected in segment revenue growth: Healthcare up 9.5% YoY to $1,033.8M and AST up 9.7% YoY to $281.5M for Q1 FY2025
- Financial risk related to share repurchase program with $200M remaining authorization and $100M repurchased in first half FY2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Steris quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.